|
62
|
164
|
4w55A |
T4 lysozyme l99a with n-propylbenzene bound |
|
155
|
506
|
4wtvA |
Crystal structure of the phosphatidylinositol 4-kinase iibeta |
|
62
|
164
|
4w54A |
T4 lysozyme l99a with ethylbenzene bound |
|
61
|
164
|
4w52A |
T4 lysozyme l99a with benzene bound |
|
63
|
164
|
4w57A |
T4 lysozyme l99a with n-butylbenzene bound |
|
60
|
164
|
4w53A |
T4 lysozyme l99a with toluene bound |
|
61
|
164
|
4w59A |
T4 lysozyme l99a with n-hexylbenzene bound |
|
61
|
164
|
4w56A |
T4 lysozyme l99a with sec-butylbenzene bound |
|
59
|
164
|
4w51A |
T4 lysozyme l99a with no ligand bound |
|
61
|
165
|
4w58A |
T4 lysozyme l99a with n-pentylbenzene bound |
|
116
|
374
|
4tn3A |
Structure of the bbox-coiled-coil region of rhesus trim5alpha |
|
47
|
162
|
4uisG |
The cryoem structure of human gamma-secretase complex |
|
134
|
436
|
4u14A |
Structure of the m3 muscarinic acetylcholine receptor bound to the antagonist tiotropium crystallized with disulfide-stabilized t4 lysozyme (dst4l) |
|
55
|
162
|
4s0wA |
Wild type t4 lysozyme structure |
|
162
|
457
|
4qkxA |
Structure of beta2 adrenoceptor bound to a covalent agonist and an engineered nanobody |
|
160
|
425
|
4oo9A |
Structure of the human class c gpcr metabotropic glutamate receptor 5 transmembrane domain in complex with the negative allosteric modulator mavoglurant |
|
154
|
512
|
4plaA |
Crystal structure of phosphatidyl inositol 4-kinase ii alpha in complex with atp |
|
165
|
442
|
4phuA |
Crystal structure of human gpr40 bound to allosteric agonist tak-875 |
|
59
|
162
|
4pjzA |
Crystal structure of t4 lysozyme-gss-peptide in complex with teicoplanin-a2-2 |
|
61
|
166
|
4pk0A |
Crystal structure of t4 lysozyme-peptide in complex with teicoplanin-a2-2 |
|
126
|
428
|
4n9nA |
Crystal structure of saccharomyces cerevisiae upc2 transcription factor fused with t4 lysozyme |
|
164
|
457
|
4ldoA |
Structure of beta2 adrenoceptor bound to adrenaline and an engineered nanobody |
|
175
|
457
|
4ldeA |
Structure of beta2 adrenoceptor bound to bi167107 and an engineered nanobody |
|
57
|
162
|
4lzmA |
Comparison of the crystal structure of bacteriophage t4 lysozyme at low, medium, and high ionic strengths |
|
148
|
411
|
4k5yA |
Crystal structure of human corticotropin-releasing factor receptor 1 (crf1r) in complex with the antagonist cp-376395 |
|
166
|
457
|
4ldlA |
Structure of beta2 adrenoceptor bound to hydroxybenzylisoproterenol and an engineered nanobody |
|
65
|
175
|
4i7kA |
T4 lysozyme l99a/m102h with toluene bound |
|
64
|
175
|
4i7sA |
T4 lysozyme l99a/m102h with 3-trifluoromethyl-5-methyl pyrazole bound |
|
64
|
176
|
4i7pA |
T4 lysozyme l99a/m102h with 4-bromoimidazole bound |
|
76
|
256
|
4iapA |
Crystal structure of ph domain of osh3 from saccharomyces cerevisiae |
|
65
|
175
|
4i7jA |
T4 lysozyme l99a/m102h with benzene bound |
|
62
|
175
|
4i7qA |
T4 lysozyme l99a/m102h with 4-trifluoromethylimidazole bound |
|
66
|
175
|
4i7rA |
T4 lysozyme l99a/m102h with 2-(pyrazolo-1-yl) ethanol bound |
|
62
|
175
|
4i7oA |
T4 lysozyme l99a/m102h with 2-amino-5-chlorothiazole bound |
|
66
|
176
|
4i7lA |
T4 lysozyme l99a/m102h with phenol bound |
|
61
|
175
|
4i7mA |
T4 lysozyme l99a/m102h with 2-allylphenol bound |
|
65
|
175
|
4i7nA |
T4 lysozyme l99a/m102h with 1-phenyl-2-propyn-1-ol bound |
|
64
|
175
|
4i7tA |
T4 lysozyme l99a/m102h with 2-bromo-5-hydroxybenzaldehyde bound |
|
72
|
225
|
4httA |
Crystal structure of twin arginine translocase receptor- tatc in ddm |
|
154
|
461
|
4grvA |
The crystal structure of the neurotensin receptor nts1 in complex with neurotensin (8-13) |
|
50
|
162
|
4gbrB |
N-terminal t4 lysozyme fusion facilitates crystallization of a g protein coupled receptor |
|
167
|
453
|
3qakA |
Agonist bound structure of the human adenosine a2a receptor |
|
143
|
442
|
3pdsA |
Irreversible agonist-beta2 adrenoceptor complex |
|
163
|
432
|
3pblA |
Structure of the human dopamine d3 receptor in complex with eticlopride |
|
111
|
450
|
3p0gA |
Structure of a nanobody-stabilized active state of the beta2 adrenoceptor |
|
161
|
466
|
3oduA |
The 2.5 a structure of the cxcr4 chemokine receptor in complex with small molecule antagonist it1t |
|
168
|
440
|
3oe0A |
Crystal structure of the cxcr4 chemokine receptor in complex with a cyclic peptide antagonist cvx15 |
|
137
|
437
|
3oe9A |
Crystal structure of the chemokine cxcr4 receptor in complex with a small molecule antagonist it1t in p1 spacegroup |
|
166
|
439
|
3nyaA |
Crystal structure of the human beta2 adrenergic receptor in complex with the neutral antagonist alprenolol |
|
133
|
442
|
3oe6A |
Crystal structure of the cxcr4 chemokine receptor in complex with a small molecule antagonist it1t in i222 spacegroup |
